Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Kathryn Mason

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Anatomy

Chemicals & Drugs

Concepts & Ideas

Disorders

Procedures

Physiology

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Riesterer Oliver; Mason Kathryn A; Raju Uma; Yang Qiuan; Wang Li; Hittelman Walter N; Ang K Kian; Milas Luka
Enhanced response to C225 of A431 tumor xenografts growing in irradiated tumor bed.
Mason Kathryn A; Valdecanas David; Hunter Nancy R; Milas Luka
INO-1001, a novel inhibitor of poly(ADP-ribose) polymerase, enhances tumor response to doxorubicin.
Wiedenmann Nicole; Koto Masashi; Raju Uma; Milas Luka; Mason Kathryn A
Modulation of tumor radiation response with G3139, a bcl-2 antisense oligonucleotide.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Kathryn Mason (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Riesterer Oliver; Mason Kathryn A; Raju Uma; Yang Qiuan; Wang Li; Hittelman Walter N; Ang K Kian; Milas Luka
Enhanced response to C225 of A431 tumor xenografts growing in irradiated tumor bed.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2009;92(3):383-7.
2008: Mason Kathryn A; Valdecanas David; Hunter Nancy R; Milas Luka
INO-1001, a novel inhibitor of poly(ADP-ribose) polymerase, enhances tumor response to doxorubicin.
Investigational new drugs 2008;26(1):1-5.
2007: Wiedenmann Nicole; Koto Masashi; Raju Uma; Milas Luka; Mason Kathryn A
Modulation of tumor radiation response with G3139, a bcl-2 antisense oligonucleotide.
Investigational new drugs 2007;25(5):411-6.
2007: Mason Kathryn A; Gillin Michael T; Mohan Radhe; Cox James D
Preclinical biologic assessment of proton beam relative biologic effectiveness at Proton Therapy Center Houston.
International journal of radiation oncology, biology, physics 2007;68(4):968-70.
2007: Thariat Juliette; Yildirim Gokcen; Mason Kathryn A; Garden Adam S; Milas Luka; Ang K Kian
Combination of radiotherapy with EGFR antagonists for head and neck carcinoma.
International journal of clinical oncology / Japan Society of Clinical Oncology 2007;12(2):99-110.
2007: Wiedenmann Nicole; Valdecanas David; Hunter Nancy; Hyde Stephen; Buchholz Thomas A; Milas Luka; Mason Kathryn A
130-nm albumin-bound paclitaxel enhances tumor radiocurability and therapeutic gain.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(6):1868-74.
2007: Milas Luka; Fang Fu-Min; Mason Kathy A; Valdecanas David; Hunter Nancy; Koto Masashi; Ang K Kian
Importance of maintenance therapy in C225-induced enhancement of tumor control by fractionated radiation.
International journal of radiation oncology, biology, physics 2007;67(2):568-72.
2007: Liao Zhongxing; Mason Kathryn A; Milas Luka
Cyclo-oxygenase-2 and its inhibition in cancer: is there a role?
Drugs 2007;67(6):821-45.
2006: Mason Kathryn A; Neal Robert; Hunter Nancy; Ariga Hisanori; Ang Kian; Milas Luka
CpG oligodeoxynucleotides are potent enhancers of radio- and chemoresponses of murine tumors.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2006;80(2):192-8.
2006: Raju Uma; Ariga Hisanori; Koto Masashi; Lu Xueguan; Pickett Jessica; Valdecanas David; Mason Kathryn A; Milas Luka
Improvement of esophageal adenocarcinoma cell and xenograft responses to radiation by targeting cyclin-dependent kinases.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2006;80(2):185-91.
2005: Mason K A
Radiation interactions with taxanes, old and new.
Radiation research 2005;163(6):705-6.
2005: Mason Kathryn A; Ariga Hisanori; Neal Robert; Valdecanas David; Hunter Nancy; Krieg Arthur M; Whisnant John K; Milas Luka
Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(1):361-9.
2004: Iyer Radhika; Thames Howard D; Tealer Ja Rhonda; Mason Katheryn A; Evans Susan C
Effect of reduced EGFR function on the radiosensitivity and proliferative capacity of mouse jejunal crypt clonogens.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2004;72(3):283-9.
2004: Milas Luka; Mason Kathryn A; Ariga Hisanori; Hunter Nancy; Neal Robert; Valdecanas David; Krieg Arthur M; Whisnant John K
CpG oligodeoxynucleotide enhances tumor response to radiation.
Cancer research 2004;64(15):5074-7.
2004: Mason Kathy A; Hunter Nancy R; Raju Uma; Ariga Hisanori; Husain Amir; Valdecanas David; Neal Robert; Ang Kian K; Milas Luka
Flavopiridol increases therapeutic ratio of radiotherapy by preferentially enhancing tumor radioresponse.
International journal of radiation oncology, biology, physics 2004;59(4):1181-9.
2004: Andratschke Nicolaus H; Dittmann Klaus H; Mason Kathryn A; Fan Zhen; Liao Zhongxing; Komaki Ritsuko; Ang K Kian; Milas Luka
Epidermal growth factor receptor as a target to improve treatment of lung cancer.
Clinical lung cancer 2004;5(6):340-52.
2004: Brock William A; Milas Luka; Bergh Sherry; Lo Ruth; Szabó Csaba; Mason Kathy A
Radiosensitization of human and rodent cell lines by INO-1001, a novel inhibitor of poly(ADP-ribose) polymerase.
Cancer letters 2004;205(2):155-60.
2004: Nakata Eiko; Mason Kathryn A; Hunter Nancy; Husain Amir; Raju Uma; Liao Zhongxing; Ang Kian K; Milas Luka
Potentiation of tumor response to radiation or chemoradiation by selective cyclooxygenase-2 enzyme inhibitors.
International journal of radiation oncology, biology, physics 2004;58(2):369-75.
2003: Milas L; Mason K A; Ang K K
Epidermal growth factor receptor and its inhibition in radiotherapy: in vivo findings.
International journal of radiation biology 2003;79(7):539-45.
2003: Raju Uma; Nakata Eiko; Mason Kathy A; Ang K Kian; Milas Luka
Flavopiridol, a cyclin-dependent kinase inhibitor, enhances radiosensitivity of ovarian carcinoma cells.
Cancer research 2003;63(12):3263-7.
2003: Liao Zhongxing; Komaki Ritsuko; Mason Kathryn A; Milas Luka
Role of cyclooxygenase-2 inhibitors in combination with radiation therapy in lung cancer.
Clinical lung cancer 2003;4(6):356-65.
2003: Milas Luka; Mason Kathryn A; Crane Christopher H; Liao Zhongxing; Masferrer Jaime
Improvement of radiotherapy or chemoradiotherapy by targeting COX-2 enzyme.
Oncology (Williston Park, N.Y.) 2003;17(5 Suppl 5):15-24.
2003: Milas Luka; Mason Kathryn A; Hunter Nancy; Li Chun; Wallace Sidney
Poly(L-glutamic acid)-paclitaxel conjugate is a potent enhancer of tumor radiocurability.
International journal of radiation oncology, biology, physics 2003;55(3):707-12.
2003: Milas Luka; Mason Kathryn A; Liao Zhongxing; Ang Kian K
Chemoradiotherapy: emerging treatment improvement strategies.
Head & neck 2003;25(2):152-67.
2002: Milas Luka; Akimoto Tetsuo; Hunter Nancy R; Mason Kathyrn A; Buchmiller Lara; Yamakawa Michitaka; Muramatsu Hiroyuki; Ang K Kian
Relationship between cyclin D1 expression and poor radioresponse of murine carcinomas.
International journal of radiation oncology, biology, physics 2002;52(2):514-21.
2001: Mason K A; Komaki R; Cox J D; Milas L
Biology-based combined-modality radiotherapy: workshop report.
International journal of radiation oncology, biology, physics 2001;50(4):1079-89.
2001: Evans S C; Mack D C; Mason K A; Thames H D
The proliferative response of mouse jejunal crypt cells to radiation-induced cell depletion is not mediated exclusively by transforming growth factor alpha.
Radiation research 2001;155(6):866-9.
2001: Weil M M; Xia C; Xia X; Gu X; Amos C I; Mason K A
A chromosome 15 quantitative trait locus controls levels of radiation-induced jejunal crypt cell apoptosis in mice.
Genomics 2001;72(1):73-7.
2001: Phan T P; Crane C H; Janjan N A; Vrdoljak E; Milas L; Mason K A
WR-2721 reduces intestinal toxicity from concurrent gemcitabine and radiation treatment.
International journal of pancreatology : official journal of the International Association of Pancreatology 2001;29(1):19-23.
2000: Kirichenko A V; Mason K A; Straume M; Teates C D; Rich T A
Nuclear scintigraphic assessment of radiation-induced intestinal dysfunction.
Radiation research 2000;153(2):164-72.
1999: Mason K A; Kishi K; Hunter N; Buchmiller L; Akimoto T; Komaki R; Milas L
Effect of docetaxel on the therapeutic ratio of fractionated radiotherapy in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(12):4191-8.
1999: Schimming R; Hunter N R; Mason K A; Milas L
[Inhibition of tumor neo-angiogenesis and induction of apoptosis as properties of docetaxel (taxotere)]
Mund-, Kiefer- und Gesichtschirurgie : MKG 1999;3(4):210-2.
1999: Mason K A; Milas L; Hunter N R; Elshaikh M; Buchmiller L; Kishi K; Hittelman K; Ang K K
Maximizing therapeutic gain with gemcitabine and fractionated radiation.
International journal of radiation oncology, biology, physics 1999;44(5):1125-35.
1999: Milas L; Milas M M; Mason K A
Combination of taxanes with radiation: preclinical studies.
Seminars in radiation oncology 1999;9(2 Suppl 1):12-26.
1999: Schimming R; Mason K A; Hunter N; Weil M; Kishi K; Milas L
Lack of correlation between mitotic arrest or apoptosis and antitumor effect of docetaxel.
Cancer chemotherapy and pharmacology 1999;43(2):165-72.
1998: Ruifrok A C; Weil M M; Mason K A; Thames H D
Induction of transforming growth factor alpha in irradiated mouse jejunum.
International journal of radiation oncology, biology, physics 1998;42(5):1137-46.
1998: Ruifrok A C; Weil M M; Thames H D; Mason K A
Diurnal variations in the expression of radiation-induced apoptosis.
Radiation research 1998;149(4):360-5.
1997: Mason K A; Hunter N R; Milas M; Abbruzzese J L; Milas L
Docetaxel enhances tumor radioresponse in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(12 Pt 1):2431-8.
1997: Milross C G; Mason K A; Hunter N R; Terry N H; Patel N; Harada S; Jibu T; Seong J; Milas L
Enhanced radioresponse of paclitaxel-sensitive and -resistant tumours in vivo.
European journal of cancer (Oxford, England : 1990) 1997;33(8):1299-308.
1997: Thames H D; Ruifrok A C; Mason K A
The effect of proliferative status and clonogen content on the response of mouse jejunal crypts to split-dose irradiation.
Radiation research 1997;147(2):172-8.
1997: Ruifrok A C; Mason K A; Lozano G; Thames H D
Spatial and temporal patterns of expression of epidermal growth factor, transforming growth factor alpha and transforming growth factor beta 1-3 and their receptors in mouse jejunum after radiation treatment.
Radiation research 1997;147(1):1-12.
1997: Milross C G; Tucker S L; Mason K A; Hunter N R; Peters L J; Milas L
The effect of tumor size on necrosis and polarographically measured pO2.
Acta oncologica (Stockholm, Sweden) 1997;36(2):183-9.
1996: Weil M M; Amos C I; Mason K A; Stephens L C
Genetic basis of strain variation in levels of radiation-induced apoptosis of thymocytes.
Radiation research 1996;146(6):646-51.
1996: Weil M M; Stephens L C; Amos C I; Ruifrok A C; Mason K A
Strain difference in jejunal crypt cell susceptibility to radiation-induced apoptosis.
International journal of radiation biology 1996;70(5):579-85.
1996: Komaki R; Fujii T; Perkins P; Ro J Y; Allen P K; Mason K A; Mountain C F; Milas L
Apoptosis and mitosis as prognostic factors in pathologically staged N1 nonsmall cell lung cancer.
International journal of radiation oncology, biology, physics 1996;36(3):601-5.
1996: Milross C G; Mason K A; Hunter N R; Chung W K; Peters L J; Milas L
Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel.
Journal of the National Cancer Institute 1996;88(18):1308-14.
1996: Milas L; Saito Y; Hunter N; Milross C G; Mason K A
Therapeutic potential of paclitaxel-radiation treatment of a murine ovarian carcinoma.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1996;40(2):163-70.
1996: Thames H D; Ruifrok A C; Milas L; Hunter N; Mason K A; Terry N H; White R A
Accelerated repopulation during fractionated irradiation of a murine ovarian carcinoma: downregulation of apoptosis as a possible mechanism.
International journal of radiation oncology, biology, physics 1996;35(5):951-62.
1996: Ruifrok A C; Mason K A; Thames H D
Changes in clonogen number and radiation sensitivity in mouse jejunal crypts after treatment with dimethylsulfoxide and retinoic acid.
Radiation research 1996;145(6):740-5.
1996: Meyn R E; Stephens L C; Mason K A; Medina D
Radiation-induced apoptosis in normal and pre-neoplastic mammary glands in vivo: significance of gland differentiation and p53 status.
International journal of cancer. Journal international du cancer 1996;65(4):466-72.
1996: Milas L; Milross C G; Mason K A
Cytotoxic treatments and tumor oxygenation.
The cancer journal from Scientific American 1996;2(1):59-60; author reply 60-1.
1995: Milross C G; Peters L J; Hunter N R; Mason K A; Milas L
Sequence-dependent antitumor activity of paclitaxel (taxol) and cisplatin in vivo.
International journal of cancer. Journal international du cancer 1995;62(5):599-604.
1995: Milas L; Hunter N R; Mason K A; Milross C G; Saito Y; Peters L J
Role of reoxygenation in induction of enhancement of tumor radioresponse by paclitaxel.
Cancer research 1995;55(16):3564-8.
1995: Mason K A; Milas L; Peters L J
Effect of paclitaxel (taxol) alone and in combination with radiation on the gastrointestinal mucosa.
International journal of radiation oncology, biology, physics 1995;32(5):1381-9.
1995: Milas L; Hunter N R; Kurdoglu B; Mason K A; Meyn R E; Stephens L C; Peters L J
Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol.
Cancer chemotherapy and pharmacology 1995;35(4):297-303.
1995: Milas L; Hunter N; Mason K A; Milross C; Peters L J
Tumor reoxygenation as a mechanism of taxol-induced enhancement of tumor radioresponse.
Acta oncologica (Stockholm, Sweden) 1995;34(3):409-12.
1994: Ruifrok A C; Mason K A; Hunter N; Thames H D
Changes in the radiation sensitivity of mouse skin during fractionated and prolonged treatments.
Radiation research 1994;139(3):334-43.
1994: Milas L; Hunter N R; Mason K A; Kurdoglu B; Peters L J
Enhancement of tumor radioresponse of a murine mammary carcinoma by paclitaxel.
Cancer research 1994;54(13):3506-10.
1994: Mason K A; Thames H D; Ochran T G; Ruifrok A C; Janjan N
Comparison of continuous and pulsed low dose rate brachytherapy: biological equivalence in vivo.
International journal of radiation oncology, biology, physics 1994;28(3):667-71.
1994: Mason K A; Tofilon P J
Unexpected radiation protection with 13-cis-retinoic acid plus interferon alpha-2a.
Cancer chemotherapy and pharmacology 1994;33(5):435-7.
1993: Mason K A; Murphy S; Milas L
Stimulation of hematopoietic cell recovery by tetrachlorodecaoxide in sublethally irradiated mice.
Radiation research 1993;136(2):229-35.
1993: Mason K A; Withers H R; Chiang C S
Late effects of radiation on the lumbar spinal cord of guinea pigs: re-treatment tolerance.
International journal of radiation oncology, biology, physics 1993;26(4):643-8.
1993: Withers H R; Mason K A; Taylor J M; Kim D K; Smathers J B
Dose-survival curves, alpha/beta ratios, RBE values, and equal effect per fraction for neutron irradiation of jejunal crypt cells.
Radiation research 1993;134(3):295-300.
1993: Withers H R; Mason K A; Taylor J M
The number of clonogenic cells in a mouse jejunal crypt.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1993;26(3):238-43.
1992: Chiang C S; Mason K A; Withers H R; McBride W H
Alteration in myelin-associated proteins following spinal cord irradiation in guinea pigs.
International journal of radiation oncology, biology, physics 1992;24(5):929-37.
1991: Taylor J M; Withers H R; Mason K A; Davis C A
Repopulation of mouse jejunal crypt cells.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1991;20(3):181-90.
1991: Tucker S L; Thames H D; Brown B W; Mason K A; Hunter N R; Withers H R
Direct analyses of in vivo colony survival after single and fractionated doses of radiation.
International journal of radiation biology 1991;59(3):777-95.
1991: Meyn R E; Peters L J; Mills M D; Moyers M F; Fields R S; Withers H R; Mason K A
Radiobiological aspects of electron beams.
Frontiers of radiation therapy and oncology 1991;25():53-60.
1989: McBride W H; Mason K A; Davis C; Withers H R; Smathers J B
Adhesion formation in experimental chronic radiation enteropathy.
International journal of radiation oncology, biology, physics 1989;16(3):737-43.
1989: Mason K A; Withers H R; McBride W H; Davis C A; Smathers J B
Comparison of the gastrointestinal syndrome after total-body or total-abdominal irradiation.
Radiation research 1989;117(3):480-8.
1989: Mason K A; Withers H R; Davis C A
Dose dependent latency of fatal gastrointestinal and bone marrow syndromes.
International journal of radiation biology 1989;55(1):1-5.
1987: Mason K A; Wu J T; Withers H R; Peters L J
Palliative radiotherapy of a mouse mammary carcinoma.
International journal of radiation oncology, biology, physics 1987;13(12):1875-82.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Kathryn Mason

Research Profile (preview)

Living Beings

Anatomy

Chemicals & Drugs

Concepts & Ideas

Disorders

Procedures

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Kathryn Mason (preview)

All Publications